Top Anti Cancer Imported Medicine Drugs in India - Pharma Five

Pharma Five is a registered firm based in India. We specialize in Named Patient Imports, Imported cancer drugs, Imported medicines in india.

Contact Us Pharma Five Door No. 74, Old No. 26, Fagun Mansion, 3rd Floor, Ethiraj Salai, Egmore, Chennai - 600008 +916374297988 info@pharmafive.org
Buy Atriance (Nelarabine) Medicine in India

Atriance (Nelarabine)

Medicine name : Atriance

Generic name : Nelarabine

Manufactured By : Hexal

Indications : T-Cell ALL and T-Cell lymphoblastic Lymphoma

Medicine Description : Atriance is used to treat T-cell acute lymphoblastic leukemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LBL). It works by inhibiting DNA synthesis, leading to cancer cell death. Administered via IV, it is effective in relapsed or refractory cases. Side effects may include nerve damage, drowsiness, and blood count reductions. Regular monitoring is required to manage neurological and hematologic risks.

Product Introduction

Atriance (Nelarabine) is an anticancer treatment used to treat certain types of blood cancer, particularly T-cell acute lymphoblastic leukaemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LBL). It works by interfering with the growth and survival of abnormal T-cells, helping to slow the progression of the cancer. Atriance (Nelarabine) should be administered strictly as directed by a healthcare professional. The treatment schedule and dosage are determined based on the patient's condition and response to therapy. Regular medical check-ups and blood tests may be required to monitor treatment response and identify possible side effects.

Common side effects of Atriance (Nelarabine) may include fatigue, nausea, vomiting, diarrhea, constipation, headache, fever, and reduced blood cell counts. Some patients may also experience nervous system-related effects such as numbness, tingling, weakness, or difficulty with coordination. Inform your doctor if any side effect becomes severe or persistent.

Before starting treatment with Atriance (Nelarabine), inform your doctor about your medical history and all medicines or supplements you are taking. Your doctor may monitor your blood counts and neurological health during treatment. Contact your doctor promptly if you develop unusual weakness, numbness, tingling, problems with walking or coordination, seizures, or other changes affecting the nervous system. Pregnant women should consult their doctor before treatment, as Nelarabine may harm an unborn baby.

Uses Of Atriance (Nelarabine)

T-cell acute lymphoblastic leukaemia and T-cell lymphoblastic lymphoma

Benefits Of Atriance

Atriance (Nelarabine) is used to help treat T-cell acute lymphoblastic leukaemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LBL), blood cancers involving abnormal T-cells. It works by interfering with the growth and survival of these cancer cells, helping to control the disease and reduce cancer cell growth, which may help slow its progression.

Side Effects Of Atriance (Nelarabine)

Some side effects of Atriance (Nelarabine) may improve as your body adjusts to the treatment. Consult your doctor if any side effect persists, becomes severe, or causes concern.

Common Side Effects of Atriance (Nelarabine)

  • Fatigue
  • Nausea
  • Vomiting
  • Headache
  • Diarrhea
  • Fever
  • Constipation
  • Decreased blood cell counts
  • Numbness or tingling
  • Muscle weakness
How To Use Atriance

Atriance (Nelarabine) is administered by a healthcare professional through an intravenous infusion. The dose and treatment schedule are determined by your doctor based on your condition and response to treatment. Do not self-administer Atriance (Nelarabine) or change the prescribed treatment schedule. Regular monitoring may be required during treatment.

How Atriance (Nelarabine) Works

Atriance (Nelarabine) works by interfering with the DNA synthesis of abnormal T-cells. After being converted into its active form inside the body, it disrupts the growth and multiplication of cancer cells, eventually causing them to die. This helps slow the progression of T-cell acute lymphoblastic leukaemia and T-cell lymphoblastic lymphoma.

Storage Conditions
  • Keep the injection at a controlled room temperature between 15°C and 30°C.
  • Keep the product protected from direct exposure to sunlight.
  • Leave the vial in its original packaging until it is ready for use.
  • Store the medicine in a secure place that is inaccessible to children.
Safety Advice

AlcoholAlcohol CONSULT YOUR DOCTOR

Avoid alcohol unless your doctor confirms it is safe, as it may worsen certain side effects.

PregnancyPregnancy CONSULT YOUR DOCTOR

Atriance (Nelarabine) may harm an unborn baby. Inform your doctor if you are pregnant or planning to become pregnant. Use effective contraception as advised.

BreastfeedingBreastfeeding CONSULT YOUR DOCTOR

Breastfeeding is not recommended during treatment with Atriance (Nelarabine). Ask your doctor when it is safe to resume breastfeeding.

DrivingDriving CONSULT YOUR DOCTOR

Atriance (Nelarabine) may cause dizziness, drowsiness, weakness, or other nervous system effects. Avoid driving if you experience these symptoms.

KidneyKidney CAUTION

Tell your doctor if you have kidney problems. Your doctor will determine whether any dose adjustment or additional monitoring is needed.

LiverLiver CAUTION

Inform your doctor about any liver problems before starting treatment. Your doctor may monitor your liver function during therapy.

Quick Tips
  • Atriance (Nelarabine) should be administered only by a healthcare professional according to your prescribed treatment schedule.
  • Attend all scheduled blood tests and medical appointments so your doctor can monitor your blood counts and overall response to treatment.
  • Inform your doctor immediately if you develop numbness, tingling, weakness, difficulty walking, or problems with coordination.
  • Tell your doctor about all medicines, vitamins, herbal products, and supplements you are taking before starting treatment.
  • Contact your doctor promptly if you develop fever, unusual bleeding or bruising, severe weakness, or any new or worsening symptoms during treatment.
  • Read More About - Atriance (Nelarabine) from Pharma Five.
About Pharma Five

Pharma Five, can facilitate the import of Atriance (Nelarabine) in small quantities for personal medical use. To proceed with the import, the applicant must submit an application in Form 12A along with a valid prescription from a Registered Medical Practitioner (RMP).

With more than two decades of experience in the pharmaceutical sector, Pharma Five provides professional assistance to patients seeking access to Atriance (Nelarabine) and other specialized medicines through appropriate import facilitation services. Pharma Five provides extensive pharmaceutical service coverage across India, serving patients and healthcare requirements in prominent cities such as Mumbai, Delhi, Kolkata, Bhubaneswar, Bangalore, Hyderabad, Chennai, Ahmedbad, Pune, Surat, Visakhapatnam, Jaipur, Lucknow, Nagpur, Indore, Patna, Agartala, Guwahati, Imphal, Kohima, Namchi, Noida, Ghaziabad, Ludhiana, Agra, Varanasi, Srinagar, Amritsar, Jodhpur, Chandigarh, Gurgaon, Gorakhpur, Dehradun, Jammu, Hyderabad, Thiruvananthapuram, Kochi, Coimbatore, Puducherry, Mysuru, Salem, Vellore, Tiruppur, Guntur, Goa, Kolhapur, Mumbai, Nashik, and various other regions in India.

References
  1. https://go.drugbank.com/drugs/DB01280
  2. https://www.ema.europa.eu/en/medicines/human/EPAR/atriance
  3. https://www.ncbi.nlm.nih.gov/books/NBK598222/
  4. https://www.cancerresearchuk.org/about-cancer/treatment/drugs/nelarabine
Faq

General Question

Atriance Medicine (Nelarabine) is a prescription chemotherapy drug used to treat certain types of T-cell acute lymphoblastic leukemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LBL), especially when other treatments haven’t worked.

Atriance Medicine is a type of antineoplastic (anti-cancer) agent that interferes with DNA synthesis in cancer cells, preventing them from growing and multiplying.

Doctors prescribe Atriance for both adults and children with relapsed or refractory T-ALL or T-LBL who have not responded to previous treatments.

Atriance is given as an intravenous (IV) infusion by a healthcare provider in a clinical setting, usually over several days in treatment cycles.

Common side effects of Atriance include fatigue, nausea, vomiting, diarrhea, headache, and low blood cell counts (anemia, neutropenia).

Yes, Atriance may cause serious side effects like neurotoxicity (numbness, weakness), infections due to low white blood cells, and breathing problems. Inform your doctor immediately if you notice any severe symptoms.

Atriance is usually given in cycles, and the duration depends on your response to the treatment and tolerance to side effects, as determined by your doctor.

Avoid alcohol during treatment with Atriance, as it can increase the risk of liver damage and worsen side effects like drowsiness or dizziness.

No, Atriance may cause harm to an unborn baby. Women of childbearing age should use effective contraception during treatment and inform their doctor if pregnant or planning pregnancy.

Yes, Atriance may interact with other drugs, especially those affecting the nervous system or bone marrow. Always share your full medication list with your doctor.

Since Atriance is administered in a medical setting, missed doses are managed by your healthcare provider. Always attend scheduled appointments.

Atriance is not taken orally; it is given by IV infusion, so food intake does not affect its administration.

Avoid activities that may increase your risk of injury, infection, or exposure to illness due to weakened immunity. Notify your doctor of any neurological changes or unusual symptoms.

Atriance is stored and handled by medical professionals in a clinical setting and does not require home storage.

Atriance is administered in hospitals or oncology clinics under medical supervision. Your oncologist will guide you on the treatment location and scheduling. Pharma Five assists in its procurement.

Timely Service
Doorstep Delivery
Hassle-Free Process
100% Genuine Sources